Navigation Links
UBM TechInsights Expands Presence in the Medical Devices Sector
Date:9/7/2010

OTTAWA, Ontario, Sept. 7 /PRNewswire/ -- UBM TechInsights is pleased to announce it has hired Gary Johnson as the new Vice President, Business Development, Medical Devices. In this role Mr. Johnson will be responsible for the continued expansion of company's business in the Medical Devices sector.

(Photo:  http://photos.prnewswire.com/prnh/20100907/SF60618)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100907/SF60618)

Mr. Johnson comes to UBM TechInsights from Texas Instruments where he worked for the past three years as Global Medical Sales Manager.  In that role he led the strategy and business development of the company's entry in to the Implantable Medical market creating partnerships with key accounts that resulted in valuable design wins.

Prior to Texas Instruments Mr. Johnson served as Director of Medical Business Development at AMI Semiconductor where he managed the business development activities of their top medical customers.  He also worked with the engineering and medical business units to map new product technology roadmaps to short and long term sales objectives.  Mr. Johnson received his Bachelor of Science - Electrical Engineering from the University of Minneapolis, Minnesota.

"With the increased availability of consumer grade medical devices, companies need a partner like UBM TechInsights who possess both the technical and intellectual property management expertise to support their technical innovation, cost control and IP management efforts. Gary is an experienced strategist with a strong technical background," said Harry Page, chief executive officer, UBM TechInsights "he will serve a vital role in expanding our presence in the growing medical devices marketplace.

UBM TechInsights provides technical analyses and IP services to companies operating in the electronics marketplace.  The company is an acknowledged thought leader in intellectual property rights management and performs teardowns of medical devices.

About UBM TechInsights

UBM TechInsights is the preeminent firm for the provision of sophisticated information and advice to technology companies. We assist in the management of their technology and intellectual property portfolios, ensuring the reduction of risk and maximizing return on investment. Our leadership position is founded upon our commitment to the utmost integrity, and sustained by the ongoing investment and acquisition of the knowledge and capabilities necessary to meet our clients' evolving needs. When companies need assistance in managing their most complex technology or IP challenges, they turn to UBM TechInsights for assured results. For more information about UBM TechInsights, go to www.ubmtechinsights.com.


'/>"/>
SOURCE UBM TechInsights
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):